Selected research
Industry Research
One-Stop Service for Gene-Edited Cell Lines Industry Research Report 2026
Market perspective
The global One-Stop Service for Gene-Edited Cell Lines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the One-Stop Service for Gene-Edited Cell Lines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the One-Stop Service for Gene-Edited Cell Lines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the One-Stop Service for Gene-Edited Cell Lines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of One-Stop Service for Gene-Edited Cell Lines include Amsbio, Charles River Laboratories, Creative Biogene, Cytiva, Eurofins Genomics, Evotec, GenScript, Horizon Discovery and Lonza, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global One-Stop Service for Gene-Edited Cell Lines market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to One-Stop Service for Gene-Edited Cell Lines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
One-Stop Service for Gene-Edited Cell Lines Market by Company
Amsbio
Charles River Laboratories
Creative Biogene
Cytiva
Eurofins Genomics
Evotec
GenScript
Horizon Discovery
Lonza
ViroCell Biologics
Sartorius
Synbio Technologies
Takara Bio
Thermo Fisher Scientific
BoyaLife
HEMABIO
BGI Genomics
GenScript Biotech
Shanghai Model Organisms
Vazyme
One-Stop Service for Gene-Edited Cell Lines Segment by Type
Gene Knockout Service
Gene Knockin Service
One-Stop Service for Gene-Edited Cell Lines Segment by Application
Universities and Research Institutions
Biopharmaceutical Industry
Others
One-Stop Service for Gene-Edited Cell Lines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global One-Stop Service for Gene-Edited Cell Lines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of One-Stop Service for Gene-Edited Cell Lines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of One-Stop Service for Gene-Edited Cell Lines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of One-Stop Service for Gene-Edited Cell Lines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Knockout Service
- Gene Knockin Service
Applications
- Universities and Research Institutions
- Biopharmaceutical Industry
- Others
Companies covered
- Amsbio
- Charles River Laboratories
- Creative Biogene
- Cytiva
- Eurofins Genomics
- Evotec
- GenScript
- Horizon Discovery
- Lonza
- ViroCell Biologics
- Sartorius
- Synbio Technologies
- Takara Bio
- Thermo Fisher Scientific
- BoyaLife
- HEMABIO
- BGI Genomics
- GenScript Biotech
- Shanghai Model Organisms
- Vazyme
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 One-Stop Service for Gene-Edited Cell Lines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Gene Knockout Service
- 2.2.3 Gene Knockin Service
- 2.3 One-Stop Service for Gene-Edited Cell Lines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Universities and Research Institutions
- 2.3.3 Biopharmaceutical Industry
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 One-Stop Service for Gene-Edited Cell Lines Breakdown Data by Type
- 3.1 Global One-Stop Service for Gene-Edited Cell Lines Historic Market Size by Type (2021-2026)
- 3.2 Global One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Type (2027-2032)
4 One-Stop Service for Gene-Edited Cell Lines Breakdown Data by Application
- 4.1 Global One-Stop Service for Gene-Edited Cell Lines Historic Market Size by Application (2021-2026)
- 4.2 Global One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global One-Stop Service for Gene-Edited Cell Lines Market Perspective (2021-2032)
- 5.2 Global One-Stop Service for Gene-Edited Cell Lines Growth Trends by Region
- 5.2.1 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 One-Stop Service for Gene-Edited Cell Lines Historic Market Size by Region (2021-2026)
- 5.2.3 One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Region (2027-2032)
- 5.3 One-Stop Service for Gene-Edited Cell Lines Market Dynamics
- 5.3.1 One-Stop Service for Gene-Edited Cell Lines Industry Trends
- 5.3.2 One-Stop Service for Gene-Edited Cell Lines Market Drivers
- 5.3.3 One-Stop Service for Gene-Edited Cell Lines Market Challenges
- 5.3.4 One-Stop Service for Gene-Edited Cell Lines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top One-Stop Service for Gene-Edited Cell Lines Players by Revenue
- 6.1.1 Global Top One-Stop Service for Gene-Edited Cell Lines Players by Revenue (2021-2026)
- 6.1.2 Global One-Stop Service for Gene-Edited Cell Lines Revenue Market Share by Players (2021-2026)
- 6.2 Global One-Stop Service for Gene-Edited Cell Lines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of One-Stop Service for Gene-Edited Cell Lines Head Office and Area Served
- 6.4 Global One-Stop Service for Gene-Edited Cell Lines Players, Product Type & Application
- 6.5 Global One-Stop Service for Gene-Edited Cell Lines Manufacturers Established Date
- 6.6 Global One-Stop Service for Gene-Edited Cell Lines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
- 7.2 North America One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 7.4 North America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
- 8.2 Europe One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 8.4 Europe One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
- 9.2 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
- 10.2 South America One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 10.4 South America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
- 11.2 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Amsbio
- 12.1.1 Amsbio Company Information
- 12.1.2 Amsbio Business Overview
- 12.1.3 Amsbio Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.1.4 Amsbio One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.1.5 Amsbio Recent Developments
- 12.2 Charles River Laboratories
- 12.2.1 Charles River Laboratories Company Information
- 12.2.2 Charles River Laboratories Business Overview
- 12.2.3 Charles River Laboratories Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.2.4 Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.2.5 Charles River Laboratories Recent Developments
- 12.3 Creative Biogene
- 12.3.1 Creative Biogene Company Information
- 12.3.2 Creative Biogene Business Overview
- 12.3.3 Creative Biogene Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.3.4 Creative Biogene One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.3.5 Creative Biogene Recent Developments
- 12.4 Cytiva
- 12.4.1 Cytiva Company Information
- 12.4.2 Cytiva Business Overview
- 12.4.3 Cytiva Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.4.4 Cytiva One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.4.5 Cytiva Recent Developments
- 12.5 Eurofins Genomics
- 12.5.1 Eurofins Genomics Company Information
- 12.5.2 Eurofins Genomics Business Overview
- 12.5.3 Eurofins Genomics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.5.4 Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.5.5 Eurofins Genomics Recent Developments
- 12.6 Evotec
- 12.6.1 Evotec Company Information
- 12.6.2 Evotec Business Overview
- 12.6.3 Evotec Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.6.4 Evotec One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.6.5 Evotec Recent Developments
- 12.7 GenScript
- 12.7.1 GenScript Company Information
- 12.7.2 GenScript Business Overview
- 12.7.3 GenScript Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.7.4 GenScript One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.7.5 GenScript Recent Developments
- 12.8 Horizon Discovery
- 12.8.1 Horizon Discovery Company Information
- 12.8.2 Horizon Discovery Business Overview
- 12.8.3 Horizon Discovery Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.8.4 Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.8.5 Horizon Discovery Recent Developments
- 12.9 Lonza
- 12.9.1 Lonza Company Information
- 12.9.2 Lonza Business Overview
- 12.9.3 Lonza Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.9.4 Lonza One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.9.5 Lonza Recent Developments
- 12.10 ViroCell Biologics
- 12.10.1 ViroCell Biologics Company Information
- 12.10.2 ViroCell Biologics Business Overview
- 12.10.3 ViroCell Biologics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.10.4 ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.10.5 ViroCell Biologics Recent Developments
- 12.11 Sartorius
- 12.11.1 Sartorius Company Information
- 12.11.2 Sartorius Business Overview
- 12.11.3 Sartorius Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.11.4 Sartorius One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.11.5 Sartorius Recent Developments
- 12.12 Synbio Technologies
- 12.12.1 Synbio Technologies Company Information
- 12.12.2 Synbio Technologies Business Overview
- 12.12.3 Synbio Technologies Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.12.4 Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.12.5 Synbio Technologies Recent Developments
- 12.13 Takara Bio
- 12.13.1 Takara Bio Company Information
- 12.13.2 Takara Bio Business Overview
- 12.13.3 Takara Bio Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.13.4 Takara Bio One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.13.5 Takara Bio Recent Developments
- 12.14 Thermo Fisher Scientific
- 12.14.1 Thermo Fisher Scientific Company Information
- 12.14.2 Thermo Fisher Scientific Business Overview
- 12.14.3 Thermo Fisher Scientific Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.14.4 Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.14.5 Thermo Fisher Scientific Recent Developments
- 12.15 BoyaLife
- 12.15.1 BoyaLife Company Information
- 12.15.2 BoyaLife Business Overview
- 12.15.3 BoyaLife Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.15.4 BoyaLife One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.15.5 BoyaLife Recent Developments
- 12.16 HEMABIO
- 12.16.1 HEMABIO Company Information
- 12.16.2 HEMABIO Business Overview
- 12.16.3 HEMABIO Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.16.4 HEMABIO One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.16.5 HEMABIO Recent Developments
- 12.17 BGI Genomics
- 12.17.1 BGI Genomics Company Information
- 12.17.2 BGI Genomics Business Overview
- 12.17.3 BGI Genomics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.17.4 BGI Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.17.5 BGI Genomics Recent Developments
- 12.18 GenScript Biotech
- 12.18.1 GenScript Biotech Company Information
- 12.18.2 GenScript Biotech Business Overview
- 12.18.3 GenScript Biotech Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.18.4 GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.18.5 GenScript Biotech Recent Developments
- 12.19 Shanghai Model Organisms
- 12.19.1 Shanghai Model Organisms Company Information
- 12.19.2 Shanghai Model Organisms Business Overview
- 12.19.3 Shanghai Model Organisms Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.19.4 Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.19.5 Shanghai Model Organisms Recent Developments
- 12.20 Vazyme
- 12.20.1 Vazyme Company Information
- 12.20.2 Vazyme Business Overview
- 12.20.3 Vazyme Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
- 12.20.4 Vazyme One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 12.20.5 Vazyme Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst